EDGAR Filing Documents for 0001144204-16-106835

Form 8-K - Current report:

SEC Accession No. 0001144204-16-106835

Filing Date

2016-06-03

Accepted

2016-06-03 17:26:53

Documents

Period of Report

2016-06-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v441731_8k.htm	8-K	62920
2	EXHIBIT 3.1	v441731_ex3-1.htm	EX-3.1	99353
3	EXHIBIT 10.1	v441731_ex10-1.htm	EX-10.1	222454
4	EXHIBIT 10.2	v441731_ex10-2.htm	EX-10.2	126114
5	EXHIBIT 10.3	v441731_ex10-3.htm	EX-10.3	35344
6	EXHIBIT 10.4	v441731_ex10-4.htm	EX-10.4	31800
7	EXHIBIT 10.5	v441731_ex10-5.htm	EX-10.5	11893
8	EXHIBIT 99.1	v441731_ex99-1.htm	EX-99.1	15645
9	EXHIBIT 99.2	v441731_ex99-2.htm	EX-99.2	6839
10	GRAPHIC	image_001.gif	GRAPHIC	5373
11	GRAPHIC	image_002.gif	GRAPHIC	3614
12	GRAPHIC	tlogo.jpg	GRAPHIC	13043
	Complete submission text file	0001144204-16-106835.txt		644892

Mailing Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120

Business Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120 212-946-4826

Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)